← Back to all trials
Recruiting
NCT05645003
Transcranial Magnetic Stimulation Therapy in Neuropathic Painful Spinal Cord Injury Patients
Conditions: Spinal Cord Injuries, Neuropathic Pain, Neurological Diseases or Conditions
Sex: All
Ages: 20 Years – 70 Years
Phase: NA
Enrollment: 60
Sponsor: Afyonkarahisar Health Sciences University
Location: Turkey
Summary
The aim of our study is to investigate the effect of high-frequency Repetitive Transcranial Magnetic Stimulation(rTMS) therapy applied to the dorsolateral PFC (DLPFC) area on neuropathic pain in patients with spinal cord injury.
In this area, there are very few studies on the effectiveness of rTMS treatment added to medical treatment in neuropathic pain.
In addition, the number of studies comparing the effect of rTMS therapy applied to the DLFPC area is very few.
Eligibility Criteria
Inclusion Criteria:Between the ages of 20-70, who applied to the AFSU Physical Medicine and Rehabilitation inpatient service with the diagnosis of spinal cord injury andHaving spinal cord injury with neurophatic pain at least six months ago,Able to follow two-stage verbal commands,Agreeing to participate in the study voluntarily and regularly,Patients who are medically stable (no previous myocardial infarction, no musculoskeletal problems) will be included in our study.Exclusion Criteria:Having an important comorbid disease such as severe heart disease (aortic stenosis, angina, hypertrophic cardiomyopathy, arrhythmia, pacemaker) and uncontrolled hypertension,Epilepsy,History of antiepileptic drug use,Intracranial metal object,Presence of in-ear implant,Cognitive dysfunction,Lower extremity peripheral nerve injury,With malignancy and active infection,Infection on the skin in the application area,Having an open wound,Having inflammatory disease,Orthopedic injuries that can limit maximum effort contractions,Having a brain lesion or a history of drug use that will affect the seizure threshold,Patients with increased intracranial pressure or uncontrolled migraine will not be included.
Source: ClinicalTrials.gov (NCT05645003). StuddyBuddy aggregates publicly available trial information.